IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-49482-9.html
   My bibliography  Save this article

Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies

Author

Listed:
  • Xijiao Ren

    (Chongqing University)

  • Rui Xue

    (Chongqing University)

  • Yan Luo

    (Chongqing University Cancer Hospital)

  • Shuang Wang

    (Chongqing University)

  • Xinyue Ge

    (Chongqing University)

  • Xuemei Yao

    (Chongqing University)

  • Liqi Li

    (Army Medical University)

  • Junxia Min

    (Zhejiang University School of Medicine)

  • Menghuan Li

    (Chongqing University)

  • Zhong Luo

    (Chongqing University
    Chongqing University)

  • Fudi Wang

    (Zhejiang University School of Medicine
    School of Public Health Hengyang Medical School University of South China)

Abstract

Radio-immunotherapy exploits the immunostimulatory features of ionizing radiation (IR) to enhance antitumor effects and offers emerging opportunities for treating invasive tumor indications such as melanoma. However, insufficient dose deposition and immunosuppressive microenvironment (TME) of solid tumors limit its efficacy. Here we report a programmable sequential therapeutic strategy based on multifunctional fusogenic liposomes (Lip@AUR-ACP-aptPD-L1) to overcome the intrinsic radio-immunotherapeutic resistance of solid tumors. Specifically, fusogenic liposomes are loaded with gold-containing Auranofin (AUR) and inserted with multivariate-gated aptamer assemblies (ACP) and PD-L1 aptamers in the lipid membrane, potentiating melanoma-targeted AUR delivery while transferring ACP onto cell surface through selective membrane fusion. AUR amplifies IR-induced immunogenic death of melanoma cells to release antigens and damage-associated molecular patterns such as adenosine triphosphate (ATP) for triggering adaptive antitumor immunity. AUR-sensitized radiotherapy also upregulates matrix metalloproteinase-2 (MMP-2) expression that combined with released ATP to activate ACP through an “and” logic operation-like process (AND-gate), thus triggering the in-situ release of engineered cytosine-phosphate-guanine aptamer-based immunoadjuvants (eCpG) for stimulating dendritic cell-mediated T cell priming. Furthermore, AUR inhibits tumor-intrinsic vascular endothelial growth factor signaling to suppress infiltration of immunosuppressive cells for fostering an anti-tumorigenic TME. This study offers an approach for solid tumor treatment in the clinics.

Suggested Citation

  • Xijiao Ren & Rui Xue & Yan Luo & Shuang Wang & Xinyue Ge & Xuemei Yao & Liqi Li & Junxia Min & Menghuan Li & Zhong Luo & Fudi Wang, 2024. "Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49482-9
    DOI: 10.1038/s41467-024-49482-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-49482-9
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-49482-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Sahil Inamdar & Abhirami P. Suresh & Joslyn L. Mangal & Nathan D. Ng & Alison Sundem & Christopher Wu & Kelly Lintecum & Abhirami Thumsi & Taravat Khodaei & Michelle Halim & Nicole Appel & Madhan Moha, 2023. "Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    2. Peng Zhang & Aida Rashidi & Junfei Zhao & Caylee Silvers & Hanxiang Wang & Brandyn Castro & Abby Ellingwood & Yu Han & Aurora Lopez-Rosas & Markella Zannikou & Crismita Dmello & Rebecca Levine & Ting , 2023. "STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    3. Linsley Kelly & Keith E. Maier & Amy Yan & Matthew Levy, 2021. "A comparative analysis of cell surface targeting aptamers," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    4. Gang Wang & Jianlong Li & Linda Bojmar & Haiyan Chen & Zhong Li & Gabriel C. Tobias & Mengying Hu & Edwin A. Homan & Serena Lucotti & Fengbo Zhao & Valentina Posada & Peter R. Oxley & Michele Cioffi &, 2023. "Tumour extracellular vesicles and particles induce liver metabolic dysfunction," Nature, Nature, vol. 618(7964), pages 374-382, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lin-Zhou Zhang & Jie-Gang Yang & Gai-Li Chen & Qi-Hui Xie & Qiu-Yun Fu & Hou-Fu Xia & Yi-Cun Li & Jue Huang & Ye Li & Min Wu & Hai-Ming Liu & Fu-Bing Wang & Ke-Zhen Yi & Huan-Gang Jiang & Fu-Xiang Zho, 2024. "PD-1/CD80+ small extracellular vesicles from immunocytes induce cold tumours featured with enhanced adaptive immunosuppression," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    2. Arnaud Desrosiers & Rabeb Mouna Derbali & Sami Hassine & Jérémie Berdugo & Valérie Long & Dominic Lauzon & Vincent De Guire & Céline Fiset & Luc DesGroseillers & Jeanne Leblond Chain & Alexis Vallée-B, 2022. "Programmable self-regulated molecular buffers for precise sustained drug delivery," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    3. Xiaona Chen & Fanchao Meng & Yiting Xu & Tongyu Li & Xiaolong Chen & Hangxiang Wang, 2023. "Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    4. Xijiao Ren & Zhuo Cheng & Jinming He & Xuemei Yao & Yingqi Liu & Kaiyong Cai & Menghuan Li & Yan Hu & Zhong Luo, 2023. "Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer," Nature Communications, Nature, vol. 14(1), pages 1-22, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49482-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.